Life Science Partners

Life Sciences Partners (LSP) has announced that Daan Ellens has joined the firm. Previously, Ellens was the CEO of Rhein Biotech, until it merged with Berna Biotech, and he will step down from his current role of COO at Berna Biotech to join LSP. Ellens is a well-known figure in the biotech industry. With a PhD in microbiology, he worked at Organon Technika for several years, and in 1993 was recruited by Martijn Kleijwegt, managing partner at LSP, for the CEO position of Rhein Biotech. Ellens has been an active supervisory board member at LSP for several years and will, in his new role, take on the position of supervisory board member of several of LSP's investments. As such, he is currently a member of the supervisory board of 4-Antibody, the most recent LSP investment in Basel, Switzerland. Furthermore, he will be actively involved in deal sourcing, due diligence and portfolio management.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux